Insmed's ($INSM) Phase II trial of Arikayce, or inhaled liposomal amikacin for the treatment of nontuberculous mycobacterial lung infections (NTM), did not meet its ...

Amikacin sulfate 100mg/2mL, 500mg/2mL, 1g/4mL; soln for IM inj or IV infusion after dilution; contains sulfites. Give by IM inj; or IV infusion over 30–60 mins. 15mg/kg per day in 2–3 divided ...

The researchers found that ventilator-associated pneumonia developed at day 28 in 15 percent of patients in the amikacin group and 22 percent in the placebo group (difference in restricted mean ...

Latest prescription information about Amikacin/ Amikin. Learn how to pronounce the drug's name, its indications, dosage, how to take, when to take, when not to take, side effects, special ...

In addition, the combination of nebulized manuka honey at 0.37 g/mL –1 and amikacin at 1.6 mg/mL –1 inhibited growth of M. abscessus. This lower dose of amikacin may result in fewer life ...

In the latest setback, the two companies have revealed that Amikacin Inhale (NKTR-061)—their combination of the antibiotic amikacin and a novel nebulizer delivery system—performed no better ...

Credit: Getty Images. ALIS has previously been designated orphan drug status, breakthrough therapy status and a Qualified Infectious Disease Product. Insmed announced the submission of its New ...

SAN DIEGO -- Adding amikacin liposome inhalation suspension (ALIS; Arikayce) to a macrolide-based regimen appeared to reduce respiratory symptoms and improve culture conversion rates in patients ...